Yongshun Chen

6.5k total citations
20 papers, 384 citations indexed

About

Yongshun Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Yongshun Chen has authored 20 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 5 papers in Immunology. Recurrent topics in Yongshun Chen's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Yongshun Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Yongshun Chen collaborates with scholars based in China and United States. Yongshun Chen's co-authors include Ning Li, Ling Li, Bingwen Zou, You Lü, Lijuan Gao, Wenhao Guo, Hu Qiu, Shaobo Ke, Jun Lei and Haohuai Liu and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Cancer Letters.

In The Last Decade

Yongshun Chen

19 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongshun Chen China 10 187 148 119 38 36 20 384
Guohong Li China 12 49 0.3× 81 0.5× 61 0.5× 38 1.0× 19 0.5× 23 348
Xixu Zhu China 13 233 1.2× 114 0.8× 192 1.6× 92 2.4× 137 3.8× 31 544
Anxin Gu China 10 125 0.7× 102 0.7× 151 1.3× 65 1.7× 73 2.0× 14 433
Hsiang‐Lin Tsai Taiwan 15 108 0.6× 286 1.9× 220 1.8× 204 5.4× 14 0.4× 46 555
Dejun Zhou China 12 148 0.8× 107 0.7× 117 1.0× 37 1.0× 38 1.1× 39 391
Alan I. Valderrama-Treviño Mexico 4 87 0.5× 161 1.1× 101 0.8× 63 1.7× 28 0.8× 28 387
Miral S. Grandhi United States 8 91 0.5× 144 1.0× 198 1.7× 173 4.6× 30 0.8× 39 544
Xiaolin Ge China 12 126 0.7× 78 0.5× 109 0.9× 65 1.7× 67 1.9× 40 345
Changlin Zou China 10 66 0.4× 133 0.9× 108 0.9× 41 1.1× 62 1.7× 28 364
Xiaomei Gong China 10 168 0.9× 292 2.0× 109 0.9× 40 1.1× 36 1.0× 30 482

Countries citing papers authored by Yongshun Chen

Since Specialization
Citations

This map shows the geographic impact of Yongshun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongshun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongshun Chen more than expected).

Fields of papers citing papers by Yongshun Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongshun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongshun Chen. The network helps show where Yongshun Chen may publish in the future.

Co-authorship network of co-authors of Yongshun Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yongshun Chen. A scholar is included among the top collaborators of Yongshun Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongshun Chen. Yongshun Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yongshun, et al.. (2025). A telomere-to-telomere reference genome assembly of tomato cultivar ‘Heinz 1706’. Plant Communications. 101618–101618. 1 indexed citations
2.
Qiu, Hu, Lijuan Gao, Shi Wei, et al.. (2024). Elaiophylin targets EIF4B to suppress the growth of esophageal squamous cell carcinoma via the PI3K/AKT signaling pathway. Cancer Letters. 611. 217401–217401. 1 indexed citations
3.
Zhou, Zihao, Jun Lei, Peng Chen, et al.. (2024). Dihydroartemisinin remodels tumor micro-environment and improves cancer immunotherapy through inhibiting cyclin-dependent kinases. International Immunopharmacology. 139. 112637–112637. 9 indexed citations
4.
5.
Hu, Yue, Min Zhou, Jing Tang, et al.. (2023). Efficacy and Safety of Stereotactic Body Radiotherapy Combined with Camrelizumab and Apatinib in Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Clinical Cancer Research. 29(20). 4088–4097. 16 indexed citations
6.
Lei, Jun, Zihao Zhou, Mengting He, et al.. (2023). Aspirin induces immunogenic cell death and enhances cancer immunotherapy in colorectal cancer. International Immunopharmacology. 121. 110350–110350. 18 indexed citations
7.
8.
Peng, Ping, Yujie Zhang, Shuchang Zhou, et al.. (2023). EGFR-TKIs plus stereotactic body radiation therapy (SBRT) for stage IV Non-small cell lung cancer (NSCLC): A prospective, multicenter, randomized, controlled phase II study. Radiotherapy and Oncology. 184. 109681–109681. 27 indexed citations
9.
10.
Zhang, Li, Ping Peng, Yujie Zhang, et al.. (2022). Improved survival from early combined radiotherapy: A phase II clinical study and underlying mechanisms of delaying EGFR-TKI acquired resistance in patients with advanced lung cancer.. Journal of Clinical Oncology. 40(16_suppl). 9114–9114. 1 indexed citations
11.
Chen, Jiamei, Yang Yang, Bo Luo, et al.. (2022). Further predictive value of lymphovascular invasion explored via supervised deep learning for lymph node metastases in breast cancer. Human Pathology. 131. 26–37. 9 indexed citations
12.
Gao, Lijuan & Yongshun Chen. (2021). Autophagy controls programmed death‑ligand 1 expression on cancer cells (Review). Biomedical Reports. 15(4). 84–84. 24 indexed citations
13.
Bai, Hua, Peng Chen, Jin Zhou, et al.. (2021). Activating receptor KIR2DS2 bound to HLA‐C1 reveals the novel recognition features of activating receptor. Immunology. 165(3). 341–354. 8 indexed citations
14.
15.
Li, Ning, Ling Li, & Yongshun Chen. (2018). The Identification of Core Gene Expression Signature in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity. 2018(1). 3478305–3478305. 53 indexed citations
16.
17.
18.
19.
Chen, Yongshun. (2008). Experimental Study on the Effect of artesunate(Art) on HEPG-2 Cells in Vitro. Lishizhen Medicine and Materia Medica Research. 1 indexed citations
20.
Chen, Yongshun, Wenhao Guo, You Lü, & Bingwen Zou. (2008). Dose-individualized stereotactic body radiotherapy for T1–3N0 non-small cell lung cancer: Long-term results and efficacy of adjuvant chemotherapy. Radiotherapy and Oncology. 88(3). 351–358. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guohong Li Breakdown of academic impact, for papers by Xixu Zhu Breakdown of academic impact, for papers by Anxin Gu Breakdown of academic impact, for papers by Hsiang‐Lin Tsai Breakdown of academic impact, for papers by Dejun Zhou Breakdown of academic impact, for papers by Alan I. Valderrama-Treviño Breakdown of academic impact, for papers by Miral S. Grandhi Breakdown of academic impact, for papers by Xiaolin Ge Breakdown of academic impact, for papers by Changlin Zou Breakdown of academic impact, for papers by Xiaomei Gong
Rankless by CCL
2026